SABR: the new kid on the block for treatment of ventricular tachycardia?
Sudden cardiac death is responsible for 4-5 million annual deaths worldwide. The primary cause of sudden cardiac death is ventricular tachycardia (VT), a cardiac arrhythmia commonly seen in patients with structural heart disease and impaired ventricular function. Conventional VT treatment approaches include antiarrhythmic drugs (AAD), invasive catheter ablation and implantable cardioverter defibrillators (ICD). While these […]
Daniel Hunnybun, Justin Lee, Stephen Riley, Peter Metherall, Matthew Hatton
Northern General Hospital; Weston Park Cancer Centre
